Standard Contracts
WITNESSETHLicense Agreement • October 6th, 2000 • Drugabuse Sciences Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.19 DRUGABUSE SCIENCES, INC. SUPPLY AGREEMENT This Supply Agreement is made and entered into effective on and as of June 9, 2000 by and between the Pharmaceutical Group of Mallinckrodt Inc. ("Mallinckrodt") and DrugAbuse Sciences ("DAS")....Supply Agreement • October 6th, 2000 • Drugabuse Sciences Inc • Biological products, (no disgnostic substances) • New York
ARTICLE ISupply and Manufacturing Agreement • October 6th, 2000 • Drugabuse Sciences Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.29 [LOGO] DRUGABUSE SCIENCES, SA 2 rue de Crucy 44 000 Nantes France June 9, 1999 Maryvonne Hiance 35 Rue Edison 44000 Nantes Re: Employment Agreement Dear Maryvonne: On behalf of DrugAbuse Sciences, I am pleased and delighted to confirm...Employment Agreement • October 6th, 2000 • Drugabuse Sciences Inc • Biological products, (no disgnostic substances)
On behalf of DrugAbuse Sciences, I am pleased and delighted to confirm the terms of your employment with DrugAbuse Sciences, SAS, located 2 rue de Crucy 44000 Nantes.This offer is conditional upon your acceptance of the terms and conditions of this offer of employment and your execution of the attached Employee Confidential Information and Inventions Agreement. Effective June 9, 1999, you will be employed as General Manager, in charge of the European operations, reporting to the President , DAS SA.
Exhibit 10.30 [DRUGABUSE SCIENCES, INC. LETTERHEAD] February 4, 2000 Elizabeth Greetham Re: Employment Agreement Dear Liz: On behalf of DrugAbuse Sciences, I am pleased to restate the terms of your employment with DrugAbuse Sciences Inc. Your position...Employment Agreement • October 6th, 2000 • Drugabuse Sciences Inc • Biological products, (no disgnostic substances)
On behalf of DrugAbuse Sciences, I am pleased to restate the terms of your employment with DrugAbuse Sciences Inc. Your position with DrugAbuse Sciences, Inc. is Chief Financial Officer and Senior Vice President, Business Development. You report to the CEO. Your position is a full-time position.
